The consistent enrichment of ISG15 across different tumor subtypes underscores the activation of interferon-mediated pathways as a conserved feature of EC5,suggesting its potential utility as a biomarker for endothelial-driven immune modulation in BC (23). This evidence concerns the gene ISG15 and breast cancer.